About the Authors
- Shiri Weinstein
-
Affiliations Laboratory of NanoMedicine, Department of Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel, Center for Nanoscience and Nanotechnology, Tel Aviv University, Tel Aviv, Israel
- Rafi Emmanuel
-
Affiliations Laboratory of NanoMedicine, Department of Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel, Center for Nanoscience and Nanotechnology, Tel Aviv University, Tel Aviv, Israel
- Ashley M. Jacobi
-
Affiliation Integrated DNA Technologies, Inc., Coralville, Iowa, United States of America
- Avigdor Abraham
-
Affiliation Division of Hematology, Chaim Sheba Medical Center, Tel Hashomer, Israel
- Mark A. Behlke
-
Affiliation Integrated DNA Technologies, Inc., Coralville, Iowa, United States of America
- Andrew G. Sprague
-
Affiliation Alnylam Pharmaceuticals, Cambridge, Massachusetts, United States of America
- Tatiana I. Novobrantseva
-
Affiliation Alnylam Pharmaceuticals, Cambridge, Massachusetts, United States of America
- Arnon Nagler
-
Affiliation Division of Hematology, Chaim Sheba Medical Center, Tel Hashomer, Israel
- Dan Peer
-
* E-mail: peer@tauex.tau.ac.il
Affiliations Laboratory of NanoMedicine, Department of Cell Research and Immunology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel, Center for Nanoscience and Nanotechnology, Tel Aviv University, Tel Aviv, Israel
Competing Interests
MAB and AMJ are employees of IDT; AS and TIN are employees of Alnylam Pharmaceuticals. DP has financial interest in Quiet Therapeutics. The remaining authors declare no competing financial interests.
Author Contributions
Conceived and designed the experiments: SW RE DP. Performed the experiments: SW RE. Analyzed the data: SW RE DP. Contributed reagents/materials/analysis tools: AA AN MAB AMJ AS TIN. Wrote the paper: SW RE DP.